公开(公告)号：US20220323460A1

公开(公告)日：2022-10-13

申请号：US17094029

申请日：2020-11-10

申请人： Enanta Pharmaceuticals, Inc.

发明人： Brian C. Shook ,  In Jong Kim ,  Thomas P. Blaisdell ,  Jianming Yu ,  Joseph Panarese ,  Kai Lin ,  Michael H.J. Rhodin ,  Nicole V. McAllister ,  Yat Sun Or

IPC分类号： A61K31/5513 ,  C07D491/04 ,  C07D213/12 ,  C07D213/14 ,  A61K31/7056 ,  A61K39/42 ,  A61K39/395 ,  C07D403/12 ,  C07K16/10 ,  C07D217/14 ,  C07D243/24 ,  A61K45/06 ,  C07D217/12 ,  A61K31/4439 ,  C07D498/08 ,  A61P31/14

摘要： The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

公开(公告)号：US10881666B2

公开(公告)日：2021-01-05

申请号：US16145768

申请日：2018-09-28

申请人： Enanta Pharmaceuticals, Inc.

发明人： Brian C. Shook ,  In Jong Kim ,  Thomas P. Blaisdell ,  Jianming Yu ,  Joseph Panarese ,  Kai Lin ,  Michael H. J. Rhodin ,  Nicole V. McAllister ,  Yat Sun Or

IPC分类号： A61K31/5513 ,  A61P31/14 ,  C07D491/04 ,  C07D213/12 ,  C07D213/14 ,  A61K31/7056 ,  A61K39/42 ,  A61K39/395 ,  C07D403/12 ,  C07K16/10 ,  C07D217/14 ,  C07D243/24 ,  A61K45/06 ,  C07D217/12 ,  A61K31/4439 ,  C07D498/08

摘要： The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

公开(公告)号：US20190192535A1

公开(公告)日：2019-06-27

申请号：US16145768

申请日：2018-09-28

申请人： Enanta Pharmaceuticals, Inc.

发明人： Brian C. Shook ,  In Jong Kim ,  Thomas P. Blaisdell ,  Jianming Yu ,  Joseph Panarese ,  Kai Lin ,  Michael H.J. Rhodin ,  Nicole V. McAllister ,  Yat Sun Or

IPC分类号： A61K31/5513 ,  A61P31/14

CPC分类号： A61K31/5513 ,  A61K31/4439 ,  A61K31/7056 ,  A61K39/395 ,  A61K39/42 ,  A61K45/06 ,  A61P31/14 ,  C07D213/12 ,  C07D213/14 ,  C07D217/12 ,  C07D217/14 ,  C07D243/24 ,  C07D403/12 ,  C07D491/04 ,  C07D498/08 ,  C07K16/1027 ,  C07K2317/24 ,  C07K2317/76 ,  A61K2300/00

摘要： The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.